α-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro

Free Radical Biology and Medicine

Volumn 30, Issue 10, 2001, Pages 1163-1170

  Turnbull, Stuart ^a   Tabner, Brian J ^a   El Agnaf, Omar M A ^a   Moore, Susan ^a   Davies, Yvonne ^a   Allsop, David ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

synuclein; Electron spin resonance spectroscopy; Free radicals; Hydrogen peroxide; Hydroxyl radicals; Neurodegeneration; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; FREE RADICAL; GAMMA SYNUCLEIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GENE MUTATION; HUMAN; HUMAN CELL; LEWY BODY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PEROXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ALPHA-SYNUCLEIN; CELL DEATH; COPPER; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROGEN PEROXIDE; IRON; MICROSCOPY, ELECTRON; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, QUATERNARY; SYNUCLEINS; TUMOR CELLS, CULTURED;

EID: 0035873812     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00513-5     Document Type: Article

References (37)

1. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;11282-11286.
2. Jakes R., Spillantini M.G., Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 345:1994;27-32.
3. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., Saitoh T. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
4. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
5. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18:1998;107-108.
6. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. α-synuclein in Lewy bodies. Nature. 388:1997;839-840.
7. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA. 95:1998;6469-6473.
8. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4:1998;1318-1320.
9. El-Agnaf O.M.A., Jakes R., Curran M.D., Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440:1998;67-70.
10. Van der Putten H., Wiederhold K.H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W.P., Ruegg M.A., Lin S., Caroni P., Sommer B., Tolnay M., Bilbe G. Neuropathology in mice expressing human α-synuclein. J. Neurosci. 20:2000;6021-6029.
11. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in α-synuclein mice implications for neurodegenerative disorders . Science. 287:2000;1265-1269.
12. Kakizuka A. Protein precipitation a common etiology in neurodegenerative disorders? Trends Genet. 14:1998;396-402.
13. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24:1999;329-332.
14. Miranda S., Opazo C., Larrondo L.F., Muñoz F.J., Ruiz F., Leighton F., Inestrosa N.C. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Prog. Neurobiol. 62:2000;633-648.
15. Roher A.E., Chaney M.O., Kuo Y.M., Webster S.D., Stine W.B., Haverkamp L.J., Woods A.S., Cotter R.J., Tuohy J.M., Krafft G.A., Bonnell B.S., Emmerling M.R. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:1996;20631-20635.
16. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
17. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
18. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Assembly of Aβ amyloid protofibrils an in vitro model for a possible early event in Alzheimer's disease . Biochemistry. 38:1999;8972-8980.
19. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616.
20. El-Agnaf O.M.A., Jakes R., Curran M.D., Middleton D., Ingenito R., Bianchi E., Pessi A., Neill D., Wallace A. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440:1998;71-75.
21. Saha A.R., Ninkina N.N., Hanger D.P., Anderton B.H., Davies A.M., Buchman V.L. Induction of neuronal cell death by α-synuclein. Eur. J. Neurosci. 12:2000;3073-3077.
22. Bayer T.A., Jäkälä P., Hartmann T., Havas L., McLean C., Culvenor J.G., Li Q.X., Masters C.L., Falkai P., Beyreuther K. α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores. Neurosci. Lett. 266:1999;213-216.
23. Borghi R., Marchese R., Negro A., Marinelli L., Forloni G., Zaccheo D., Abbruzzese G., Tabaton M. Full-length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 287:2000;65-67.
24. Soto C., Castano E.M., Prelli F., Kumar A., Baumann M. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett. 371:1995;110-114.
25. El-Agnaf O.M.A., Goodwin H., Sheridan J.M., Frears E.R., Austen B.M. Improved solid-phase syntheses of amyloid proteins associated with neurodegenerative diseases. Protein Peptide Letts. 7:2000;1-8.
26. Dalal N.S., Newman J., Pack D., Leonard S., Vallyathan V. Hydroxyl radical generation by coal mine dust possible implications to coal workers' pneumoconiosis (CWP) . Free Radical Biol. Med. 18:1995;11-20.
27. Paik S.R., Shin H.J., Lee J.H., Chang C.S., Kim J. Copper(II)-induced self-oligomerization of α-synuclein. Biochem. J. 340:1999;821-828.
28. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., Bush A.I. Characterization of copper interactions with Alzheimer amyloid β peptides identification of an attomolar-affinity copper binding site on amyloid β1-42 . J. Neurochem. 75:2000;1219-1233.
29. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., Bush A.I. Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274:1999;37111-37116.
30. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. α-Synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157:2000;401-410.
31. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 1:1998;24-34.
32. Jenner P., Olanow C. Understanding cell death in Parkinson's disease. Ann. Neurol. 44:1998;S72-S84.
33. Alam Z., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1997;1326-1329.
34. Alam Z., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain an apparent selective increase in 8-hydroxyguanine levels in substanta nigra . J. Neurochem. 69:1997;1196-1203.
35. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.
36. Giasson B.I., Duda J.E., Murray I.V.J., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M.-Y. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989.
37. Hashimoto M., Hsu L.J., Xia Y., Takeda A., Sisk A., Sundsmo M., Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro. Neuroreport. 10:1999;717-721.